Merih Bırlık

2.4k total citations
111 papers, 1.5k citations indexed

About

Merih Bırlık is a scholar working on Pathology and Forensic Medicine, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Merih Bırlık has authored 111 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pathology and Forensic Medicine, 41 papers in Rheumatology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Merih Bırlık's work include Systemic Sclerosis and Related Diseases (40 papers), Rheumatoid Arthritis Research and Therapies (22 papers) and Spondyloarthritis Studies and Treatments (20 papers). Merih Bırlık is often cited by papers focused on Systemic Sclerosis and Related Diseases (40 papers), Rheumatoid Arthritis Research and Therapies (22 papers) and Spondyloarthritis Studies and Treatments (20 papers). Merih Bırlık collaborates with scholars based in Türkiye, Italy and United Kingdom. Merih Bırlık's co-authors include İ̇smail Sarı, Fatoş Önen, Nurullah Akkoç, Servet Akar, Timuçin Kaşifoğlu, Oğuz Gürler, G. Can, Metin Manisalı, Mustafa Seçil and Canan Altay and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Merih Bırlık

95 papers receiving 1.5k citations

Peers

Merih Bırlık
Mehmet Sayarlıoğlu Türkiye
Şeminur Haznedaroğlu Türkiye
Dilek Solmaz Türkiye
Alessandra Soriano Italy
Olga Vera‐Lastra Mexico
Sezgin Şahin Türkiye
Kenan Barut Türkiye
Fatoş Önen Türkiye
S. Morell‐Dubois France
Liza McCann United Kingdom
Mehmet Sayarlıoğlu Türkiye
Merih Bırlık
Citations per year, relative to Merih Bırlık Merih Bırlık (= 1×) peers Mehmet Sayarlıoğlu

Countries citing papers authored by Merih Bırlık

Since Specialization
Citations

This map shows the geographic impact of Merih Bırlık's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merih Bırlık with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merih Bırlık more than expected).

Fields of papers citing papers by Merih Bırlık

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merih Bırlık. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merih Bırlık. The network helps show where Merih Bırlık may publish in the future.

Co-authorship network of co-authors of Merih Bırlık

This figure shows the co-authorship network connecting the top 25 collaborators of Merih Bırlık. A scholar is included among the top collaborators of Merih Bırlık based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merih Bırlık. Merih Bırlık is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bırlık, Merih, et al.. (2025). Assessment of Factors Related to Sarcopenia in Patients with Systemic Sclerosis. Journal of Clinical Medicine. 14(5). 1573–1573.
3.
Çefle, Ayşe, Sema Yılmaz, Süleyman Serdar Koca, et al.. (2024). Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study. Scientific Reports. 14(1). 14194–14194. 5 indexed citations
4.
Kahraman, Buse Özcan, et al.. (2024). Functional capacity, physical activity, and arterial stiffness in patients with systemic sclerosis. Clinical Rheumatology. 43(5). 1657–1664.
5.
Bırlık, Merih, et al.. (2024). Patients with systemic sclerosis frequently use phytopharmaceuticals: a cross-sectional survey. Rheumatology International. 44(12). 3079–3085. 1 indexed citations
6.
Çefle, Ayşe, Fatoş Önen, Nurullah Akkoç, et al.. (2024). Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results. Archives of Rheumatology. 39(2). 232–241. 4 indexed citations
7.
Kaya, Mahmut, et al.. (2023). Evaluation of choroidal vascularity index in systemic sclerosis patients. Photodiagnosis and Photodynamic Therapy. 41. 103297–103297. 7 indexed citations
8.
Bırlık, Merih, Ali Akdoğan, Gezmiş Kimyon, et al.. (2023). Extended autoantibody panel in Turkish patients with early‐stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes. Immunity Inflammation and Disease. 11(12). e1089–e1089. 2 indexed citations
9.
Önen, Fatoş, et al.. (2022). Rituximab on lung, skin, and joint involvement in patients with systemic sclerosis: A case series study and review of the literature. International Journal of Rheumatic Diseases. 25(7). 755–768. 5 indexed citations
10.
Sarıoğlu, Sülen, et al.. (2022). Protective effects of alpha-lipoic acid on bleomycin-induced skin fibrosis through the repression of NADPH Oxidase 4 and TGF-β1/Smad3 signaling pathways. Human & Experimental Toxicology. 41. 3510084215–3510084215. 11 indexed citations
11.
Can, G., Sülen Sarıoğlu, Merih Bırlık, et al.. (2021). The prevalence of Sjögren’s syndrome and sicca symptoms in patients with systemic sclerosis and alpha-smooth muscle actin expression in biopsy specimens from minor salivary glands. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(4). 1875–1882. 4 indexed citations
12.
Can, G., et al.. (2020). SAT0344 LIMITED JOINT MOBILITY OF HAND IN SYSTEMIC SCLEROSIS PATIENTS BY USING “PRAYER” AND “TABLE TOP” SIGNS. Annals of the Rheumatic Diseases. 79. 1117–1118. 1 indexed citations
13.
Can, G., et al.. (2019). Infliximab-associated focal segmental glomerulosclerosis in a patient with ankylosing spondylitis. Rheumatology International. 39(3). 561–567. 8 indexed citations
14.
Bırlık, Merih, et al.. (2018). Effects of epigallocatechin-3-gallate (EGCG) on a scleroderma model of fibrosis. Turkish Journal of Biochemistry. 43(4). 464–473. 4 indexed citations
15.
Can, G., et al.. (2018). Gender does not make a difference in “composite psoriatic disease activity index (CPDAI)” in patients with psoriatic arthritis. Rheumatology International. 38(11). 2069–2076. 10 indexed citations
16.
Bırlık, Merih. (2013). Antinükleer Antikorların Klinikteki Kullanımı. 6(2). 6–23.
17.
Can, G., Servet Akar, Merih Bırlık, et al.. (2009). Assessment of body composition in Familial Mediterranean fever.. DergiPark (Istanbul University). 14(3). 181–185.
18.
Sarı, İ̇smail, Merih Bırlık, Can Gönen, et al.. (2008). Cytomegalovirus colitis in a patient with Behcet’s disease receiving tumor necrosis factor alpha inhibitory treatment. World Journal of Gastroenterology. 14(18). 2912–2912. 34 indexed citations
19.
Sarı, İ̇smail, Merih Bırlık, Servet Akar, et al.. (2008). Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy. Rheumatology International. 29(5). 591–593. 7 indexed citations
20.
Bırlık, Merih, Servet Akar, Emre Tüzel, et al.. (2004). Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder. Journal of Cancer Research and Clinical Oncology. 130(2). 122–125. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehmet Sayarlıoğlu Breakdown of academic impact, for papers by Şeminur Haznedaroğlu Breakdown of academic impact, for papers by Dilek Solmaz Breakdown of academic impact, for papers by Alessandra Soriano Breakdown of academic impact, for papers by Olga Vera‐Lastra Breakdown of academic impact, for papers by Sezgin Şahin Breakdown of academic impact, for papers by Kenan Barut Breakdown of academic impact, for papers by Fatoş Önen Breakdown of academic impact, for papers by S. Morell‐Dubois Breakdown of academic impact, for papers by Liza McCann
Rankless by CCL
2026